Back to results
US 2026/0077049 A1Published application
Compounds including a mutant kras sequence and a lipid and uses thereof
AssigneeElicio Therapeutics, Inc.
InventorsPeter C. DEMUTH, Julian ADAMS, Martin P. STEINBUCK
Life of this patent
Estimating the term…
Abstract
The invention provides compounds including a KRAS sequence that is linked to a lipid by a linker, and related compositions and methods.
Claims22
A compound comprising a mutant KRAS sequence and a lipid, wherein the mutant KRAS sequence is conjugated to the lipid by a linker, and (i) the linker comprises one or more polyethylene glycol blocks, (ii) the lipid is 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), and (iii) the mutant KRAS sequence consists of an amino acid sequence selected from the group consisting of
- (SEQ ID NO:
- 1)
- CYKLVVVGADGVGKSALTI,
- (SEQ ID NO:
- 2)
- CYKLVVVGAVGVGKSALTI,
- (SEQ ID NO:
- 3)
- CYKLVVVGARGVGKSALTI,
- (SEQ ID NO:
- 4)
- CYKLVVVGAAGVGKSALTI,
- (SEQ ID NO:
- 5)
- CYKLVVVGASGVGKSALTI,
- (SEQ ID NO:
- 6)
- CYKLVVVGACGVGKSALTI,
- (SEQ ID NO:
- 22)
- CYKLVVVGATGVGKSALTI,
- and
- (SEQ ID NO:
- 7)
- CYKLVVVGAGDVGKSALTI.
22 more elements
Dependencies are inferred from the claim text.